One pathway, described accurately by the seller, and genuinely well-understood physiology. The question is not whether the mechanism exists. It is whether 500 milligrams moves it.
Bloodpril works, in principle, through the endothelial nitric oxide pathway. L-arginine is the substrate that endothelial nitric oxide synthase (eNOS) converts into nitric oxide. Nitric oxide diffuses into vascular smooth muscle, activates guanylate cyclase, raises cGMP and causes the vessel to relax. Relaxed vessels dilate, peripheral resistance falls, and blood pressure falls with it. L-citrulline supports the same pathway indirectly by bypassing the arginase enzymes that destroy most oral arginine. These are ingredient-level mechanisms demonstrated at gram-scale doses; no study has measured this finished 500 mg product.
Two things before anything else, because this is a blood pressure product. First: never stop or reduce prescribed antihypertensive medication because a supplement seems to be helping. Hypertension is symptomless and the damage it does is silent. Second: L-arginine and L-citrulline work on the nitric oxide pathway — the same pathway as nitrates (nitroglycerin, isosorbide) and PDE5 inhibitors (sildenafil, tadalafil). Stacking them can drop blood pressure further than intended. And anyone who has had a heart attack should know that a controlled trial of L-arginine in post-infarction patients was stopped early over a mortality signal — a finding that appears on no page selling this ingredient. Take the label to a pharmacist or your cardiologist first.
The 1998 Nobel Prize in Physiology or Medicine was awarded for the discovery that nitric oxide acts as a signalling molecule in the cardiovascular system. That is the foundation this product stands on, and it is solid ground.
Step one: substrate availability. Endothelial cells lining your arteries contain eNOS, an enzyme that converts L-arginine into nitric oxide and L-citrulline. More arginine at the endothelium means more raw material available.
Step two: the relaxation signal. Nitric oxide diffuses from the endothelium into the smooth muscle layer of the vessel wall, where it activates soluble guanylate cyclase. That raises cyclic GMP, which reduces intracellular calcium and relaxes the muscle. The vessel widens.
Step three: the pressure effect. Widened vessels mean lower peripheral vascular resistance. Since blood pressure is a product of cardiac output and resistance, lowering resistance lowers pressure.
Why this matters for safety, not just efficacy. Nitrate medications such as nitroglycerin work by donating nitric oxide directly into this same pathway. PDE5 inhibitors such as sildenafil work by preventing the breakdown of the cGMP that nitric oxide produces. Three different routes to one effect — which is precisely why combining them is a pharmacist conversation rather than a footnote.
Actives named — 3
Blend total published — 500 mg
Per-ingredient split — not published
Serving — 2 capsules daily
Finished-product trials — none
L-arginine BP trials — 6,000–12,000 mg
L-citrulline BP trials — 3,000–6,000 mg
It would be unfair to review this product without crediting the one piece of reasoning on the seller’s page that is both correct and non-obvious.
Swallowing L-arginine is an inefficient way to raise arginine in your blood. The gut wall and liver are rich in arginase, an enzyme that breaks arginine down before it reaches circulation. This first-pass metabolism is why oral arginine trials need such large doses to show anything, and why many of them disappoint.
L-citrulline is not an arginase substrate, so it passes through untouched. It travels to the kidneys where argininosuccinate synthase converts it into arginine, which then enters circulation. The counter-intuitive result, confirmed repeatedly in human studies, is that oral citrulline raises plasma arginine more effectively than oral arginine does.
So the formula is built on a real insight. Including citrulline alongside arginine, and explaining why, is more sophisticated than most products in this category manage. The problem is what happens next: the trials establishing citrulline’s blood pressure effects used 3 to 6 grams daily. Even if the entire 500 mg blend were pure citrulline — which it is not, since two arginine forms share the space — it would sit at roughly a sixth of the low end of that range.
The official page publishes a five-stage timeline: Day 7, Day 30, Day 60, Day 90 and Day 180, each with specific promised outcomes. Day 30 says “morning readings begin trending more positively.” Day 60 says readings are “more stable and comfortable” and that “the vascular stiffness and resistance that produced elevated readings has meaningfully decreased.” Day 90 promises “comprehensive cardiovascular transformation.”
There is no basis for any of it. No trial has been run on this product. The doses that produced measurable blood pressure changes in the literature are ten to thirty times what this supplies. A timeline this specific, attached to outcomes this confident, is a sales structure rather than a physiological forecast.
One detail gives the game away. The Day 60 entry closes with: “Most users ordering the 2-bottle package reorder at this point.” That is not an observation about vascular biology. It is a prompt, placed at exactly the moment the 60-day guarantee expires.
We flag it because the rest of this seller’s page is unusually careful. The pricing is honest, the guarantee is generous, the regulatory language is correct and the mechanism is described accurately. The timeline is the one section that abandons that standard.
The per-ingredient split. If citrulline dominates the 500 mg, the product is meaningfully better than if arginine does.
A higher dose. A version supplying 3 g of citrulline would be a different conversation entirely — and would need roughly six times the capsules.
Any measurement on the finished product. Even a small before-and-after blood pressure study on actual buyers would be more than exists now.
The limitation worth repeating. Everything above is ingredient-level science at researched doses. There is no published clinical trial on the finished Bloodpril capsule. That is normal for the supplement category and not unique to this product, but it means the correct mental model is “a well-reasoned formula supplied below its researched range” rather than “a tested blood pressure product.” Our full review takes a position on whether that justifies the price.
The seller publishes a Day 7 to Day 180 timeline promising progressively better readings. We would treat that as marketing: no trial exists on this product and the researched doses are ten to thirty times what it supplies. If you try it, judge it on measured readings across fortnightly averages, and decide before day 50.
Yes, entirely. The role of nitric oxide as a cardiovascular signalling molecule earned the 1998 Nobel Prize in Physiology or Medicine, and eNOS converting arginine to nitric oxide is textbook physiology. The mechanism is not in question here; the dose is.
Because oral arginine is largely destroyed by arginase in the gut wall and liver before reaching circulation. Citrulline is not an arginase substrate, so it survives that first pass and converts to arginine in the kidneys — which is why oral citrulline raises plasma arginine more effectively than oral arginine does. It is the smartest part of the formula.
Almost certainly not at that amount. L-arginine blood pressure trials used 6–12 g daily and L-citrulline trials used 3–6 g. A 500 mg blend shared between three ingredients is roughly 3–6% of the combined researched range.
Package pricing, shipping and the 60-day guarantee, verified 2026-08-22.
Check the current Bloodpril sale price Compare packages
Redirects to the Bloodpril official website. We may earn a commission at no additional cost to you. Pricing verified 2026-08-22 — confirm your total at checkout.